These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 11413530)
21. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology. Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC Cancer; 2007 Jan; 109(2):274-81. PubMed ID: 17154161 [TBL] [Abstract][Full Text] [Related]
22. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. Cerfolio RJ; Bryant AS; Ojha B J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150 [TBL] [Abstract][Full Text] [Related]
23. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer. Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846 [TBL] [Abstract][Full Text] [Related]
24. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169 [TBL] [Abstract][Full Text] [Related]
25. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage IIIA (T1-3, N2) unresectable non-small-cell lung cancer: final results of the Toronto phase II trial. Burkes RL; Shepherd FA; Blackstein ME; Goldberg ME; Waters PF; Patterson GA; Todd T; Pearson FG; Jones D; Farooq S; McGlaughlin J; Ginsberg RJ Lung Cancer; 2005 Jan; 47(1):103-9. PubMed ID: 15603860 [TBL] [Abstract][Full Text] [Related]
26. Lung cancer and its operable brain metastasis: survival rate and staging problems. Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950 [TBL] [Abstract][Full Text] [Related]
27. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805 [TBL] [Abstract][Full Text] [Related]
28. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420 [TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer. Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383 [TBL] [Abstract][Full Text] [Related]
30. [Efficacy of permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma]. Wang ZM; Wu J; Wang GC; Ren JL; Kjelle D Ai Zheng; 2002 Oct; 21(10):1145-8. PubMed ID: 12508663 [TBL] [Abstract][Full Text] [Related]
32. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases]. Zhang GQ; Han F; Gao SL; A DL; Pang ZL Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944 [TBL] [Abstract][Full Text] [Related]
33. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer. Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y Am J Clin Oncol; 2007 Jun; 30(3):239-44. PubMed ID: 17551299 [TBL] [Abstract][Full Text] [Related]
34. [Combined therapy for stage IIIa non-small cell lung cancer]. Zhao LQ; Hou SC; Li H; Hu B; Wang Y Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2030-2. PubMed ID: 16313794 [TBL] [Abstract][Full Text] [Related]
35. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH; J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032 [TBL] [Abstract][Full Text] [Related]
36. The role of radiation therapy for carcinoma of the lung. Cox JD Yale J Biol Med; 1981; 54(3):195-200. PubMed ID: 6270918 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of subcarinal station in non-small cell lung cancer with T1-3 N2 disease. Iwasaki A; Shirakusa T; Miyoshi T; Hamada T; Enatsu S; Maekawa S; Hiratsuka M Thorac Cardiovasc Surg; 2006 Feb; 54(1):42-6. PubMed ID: 16485188 [TBL] [Abstract][Full Text] [Related]
38. Necessity of preoperative screening for brain metastasis in non-small cell lung cancer patients without lymph node metastasis. Yohena T; Yoshino I; Kitajima M; Uehara T; Kanematsu T; Teruya T; Ikeda J; Ichinose Y Ann Thorac Cardiovasc Surg; 2004 Dec; 10(6):347-9. PubMed ID: 15658906 [TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma]. Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460 [TBL] [Abstract][Full Text] [Related]
40. Brain metastases in N2-positive non-small-cell lung cancer: implications for prophylactic cranial irradiation. Bansal M; Boyle T; Ehsan A; Mott FE Clin Lung Cancer; 2008 Jul; 9(4):227-9. PubMed ID: 18650171 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]